Activation-dependent surface expression of LOX-1 in human platelets

被引:153
作者
Chen, MY
Kakutani, M
Naruko, T
Ueda, M
Narumiya, S
Masaki, T
Sawamura, T [1 ]
机构
[1] Natl Cardiovasc Ctr, Res Inst, Osaka 5658565, Japan
[2] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan
[3] Osaka City Univ, Sch Med, Dept Pharmacol, Osaka 5458585, Japan
[4] Osaka City Gen Hosp, Dept Cardiol, Osaka 5340021, Japan
[5] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Mol Pathophysiol, Osaka 5650871, Japan
关键词
LOX-1; oxidized LDL; human;
D O I
10.1006/bbrc.2001.4516
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lectin-like oxidized LDL receptor-1 (LOX-1) was initially identified as an oxidized LDL receptor in aortic endothelial cells. Here we identified LOX-1 mRNA and protein in human platelets in addition to recent findings on the expression in macrophages and smooth muscle cells. The presence of LOX-1 was further confirmed in the megakaryocytic cell lines. Flow cytometric analyses revealed that LOX-1 was exposed on the surface of platelets in an activation-dependent manner. Consistently, the activation-dependent binding of OxLDL to platelets was mostly inhibited by anti-LOX-1 antibody. Immunohistochemistry of the atherosclerotic plaque from a patient with unstable angina pectoris (UAP) revealed accumulation of LOX-1 protein at the site of thrombus, As LOX-1 recognizes and binds activated platelets, exposure of LOX-1 on activated platelets surface might assist thrombosis formation. (C) 2001 Academic Press.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 31 条
[1]   Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene [J].
Aoyama, T ;
Sawamura, T ;
Furutani, Y ;
Matsuoka, R ;
Yoshida, MC ;
Fujiwara, H ;
Masaki, T .
BIOCHEMICAL JOURNAL, 1999, 339 :177-184
[2]   PLATELET ACTIVATION BY OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS [J].
ARDLIE, NG ;
SELLEY, ML ;
SIMONS, LA .
ATHEROSCLEROSIS, 1989, 76 (2-3) :117-124
[3]   Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: Antiatherogenic effects of HMG-CoA reductase inhibitor therapy [J].
Aviram, M ;
Hussein, O ;
Rosenblat, M ;
Schlezinger, S ;
Hayek, T ;
Keidar, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (01) :39-45
[4]   Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets - Relevance of the effect of oxidized LDL on platelet function [J].
Chen, LY ;
Mehta, P ;
Mehta, JL .
CIRCULATION, 1996, 93 (09) :1740-1746
[5]   Increased expression of lectinlike oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits [J].
Chen, MY ;
Kakutani, M ;
Minami, M ;
Kataoka, H ;
Kume, N ;
Narumiya, S ;
Kita, T ;
Masaki, T ;
Sawamura, T .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) :1107-1115
[6]   Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species [J].
Cominacini, L ;
Fratta Pasini, A ;
Garbin, U ;
Davoli, A ;
Tosetti, ML ;
Campagnola, M ;
Rigoni, A ;
Pastorino, AM ;
Lo Cascio, V ;
Sawamura, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) :12633-12638
[7]   The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin [J].
Draude, G ;
Hrboticky, N ;
Lorenz, RL .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (04) :383-386
[8]  
ENDEMANN G, 1993, J BIOL CHEM, V268, P11811
[9]   NKR-P1, A SIGNAL TRANSDUCTION MOLECULE ON NATURAL-KILLER-CELLS [J].
GIORDA, R ;
RUDERT, WA ;
VAVASSORI, C ;
CHAMBERS, WH ;
HISERODT, JC ;
TRUCCO, M .
SCIENCE, 1990, 249 (4974) :1298-1300
[10]  
Huh HY, 1996, BLOOD, V87, P2020